CIM
AZN icon

Calvert Investment Management’s AstraZeneca AZN Stock Holding History

Calvert Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-19,508
Closed -$1.07M – 69
2016
Q4 		$1.07M Sell
19,508
-2,723
-12% -$155K 0.04% 372
2016
Q3 		$1.46M Sell
22,231
-459
-2% -$30K 0.05% 331
2016
Q2 		$1.37M Hold
22,690
– – 0.06% 305
2016
Q1 		$1.28M Sell
22,690
-65,564
-74% -$3.94M 0.06% 277
2015
Q4 		$5.99M Sell
88,254
-118
-0.1% -$7.74K 0.27% 73
2015
Q3 		$5.62M Buy
88,372
+3,232
+4% +$213K 0.28% 84
2015
Q2 		$5.42M Buy
85,140
+54,609
+179% +$3.74M 0.24% 96
2015
Q1 		$2.09M Buy
30,531
+3,497
+13% +$243K 0.13% 157
2014
Q4 		$1.9M Buy
27,034
+702
+3% +$50.3K 0.13% 167
2014
Q3 		$1.88M Sell
26,332
-1,155
-4% -$84.5K 0.14% 161
2014
Q2 		$2.04M Buy
27,487
+847
+3% +$61.2K 0.14% 130
2014
Q1 		$1.73M Buy
26,640
+5,687
+27% +$367K 0.12% 141
2013
Q4 		$1.24M Buy
20,953
+14,820
+242% +$805K 0.09% 157
2013
Q3 		$318K Hold
6,133
– – 0.04% 259
2013
Q2 		$290K Buy
+6,133
New +$312K 0.04% 258

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Calvert Investment Management's AZN Position: Q1 2017 in Review

Calvert Investment Management sold out of AstraZeneca (AZN) in Q1 2017, closing a stake of 19,508 shares — an estimated $1.07M sold.

Calvert Investment Management first reported a position in AZN in Q2 2013 and held it in 15 quarters. The position peaked at $5.99M in Q4 2015. 461 funds tracked by Wall St. Rank hold AZN as of Q1 2017.

  • Calvert Investment Management reported no remaining AstraZeneca position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 19,508 AstraZeneca shares in Q1 2017, an estimated $1.07M.
  • Calvert Investment Management first reported a position in AstraZeneca in Q2 2013 and held it in 15 quarters.
  • Calvert Investment Management's AstraZeneca position peaked at $5.99M in Q4 2015.
  • 461 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.